Journal Information
Vol. 60. Issue 1.
Pages 55-58 (January 2024)
Share
Share
Download PDF
More article options
Vol. 60. Issue 1.
Pages 55-58 (January 2024)
Scientific Letter
Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
Visits
697
Juan Antonio Riesco Mirandaa,
Corresponding author
jantonio.riesco@gmail.com

Corresponding author.
, Myriam Calle Rubiob, David Díaz Pérezc, Jose Luis López-Camposd, Juan Antonio Trigueros Carreroe, Bartolomé Cellif
a Servicio de Neumología, Hospital San Pedro de Alcántara, Ciberes, Cáceres, Spain
b Servicio de Neumología, Hospital Universitario Clínico San Carlos, Madrid, Spain
c Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
d Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain
e Centro de salud Menasalbas, Menasalbas, Toledo, Spain
f Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard University Medical School, Boston, MA, USA
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Summary of the Main Results of the Meta-analysis at 52 Weeks. Green Color Represents Comparisons With Higher Level of Evidence in Favor of Single-inhaler Triple Therapy (Meta-analysis or Clear Effect From Randomized Clinical Trials). Yellow Color Depicts Contradictory Results or an Absence of Difference Between Treatment Groups Across Several Comparisons. Light Blue Color Indicates Lacking Data. For Each Result the Study References are Provided.
Table 2. Main Results of Single-inhaler Triple Therapy at 52 Weeks According to COPD Medication at Screening. Green Color Represents Comparisons With Statistically Significant Evidence in Favor of Single-inhaler Triple Therapy. Yellow Color Depicts Contradictory Results or an Absence of Difference Between Treatment Groups. Light Blue Color Indicates Lacking Data.
Show moreShow less
Additional material (1)

Article

These are the options to access the full texts of the publication Archivos de Bronconeumología
Member
If you are a member of SEPAR:
  • Go to >>>SEPAR<<< website and sign in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de Bronconeumología

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?